AGuIX Nanoparticles With Radiotherapy Plus Concomitant Temozolomide in the Treatment of Newly Diagnosed Glioblastoma
AGuIX Nanoparticles With Radiotherapy Plus Concomitant Temozolomide in the Treatment of Newly Diagnosed Glioblastoma
Active, not recruiting · NCT04881032 · Registry updated 2025-02-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| AGuIX Nanoparticles With Radiotherapy Plus Concomitant Temozolomide in the Treatment of Newly Diagnosed Glioblastoma | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Active, not recruiting | Phase 1 / Phase 2 | 2025-02-13 | NCT04881032 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Centre Jean Perrin | 15 |
| Ministry for Health and Solidarity, France | 5 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre Jean Perrin | Clermont-Ferrand | France | 58 |
| Centre Léon Berard | Lyon | France | 11 |
| CHU de Brest | Brest | France | 18 |
| Chu de Grenoble | Grenoble | France | 28 |
| Hospices Civils de Lyon | Lyon | France | 43 |
| Hôpital La Pitié Salpetrière | Paris | France | 1 |
| Institut de Cancérologie de l'Ouest | Saint-Herblain | France | 17 |
| Institut de cancérologie Strasbourg Europe | Strasbourg | France | 5 |
| Institut Gustave Roussy | Villejuif | France | 58 |